KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Teva Pharmaceutical Industries (TEVA) Liabilities from Discontinued Operations: 2013-2017

  • Teva Pharmaceutical Industries' Liabilities from Discontinued Operations fell 67.24% to $38.0 million in Q4 2017 from the same period last year, while for Dec 2017 it was $38.0 million, marking a year-over-year decrease of 67.24%. This contributed to the annual value of $38.0 million for FY2017, which is 67.24% down from last year.
  • Latest data reveals that Teva Pharmaceutical Industries reported Liabilities from Discontinued Operations of $38.0 million as of Q4 2017, which was down 0.00% from $38.0 million recorded in Q3 2017.
  • In the past 5 years, Teva Pharmaceutical Industries' Liabilities from Discontinued Operations ranged from a high of $327.0 million in Q3 2016 and a low of $38.0 million during Q3 2017.
  • Its 2-year average for Liabilities from Discontinued Operations is $129.8 million, with a median of $77.0 million in 2016.
  • Data for Teva Pharmaceutical Industries' Liabilities from Discontinued Operations shows a maximum YoY plummeted of 88.38% (in 2017) over the last 5 years.
  • Quarterly analysis of 3 years shows Teva Pharmaceutical Industries' Liabilities from Discontinued Operations stood at $246.6 million in 2013, then reached $116.0 million in 2016, then slumped by 67.24% to $38.0 million in 2017.
  • Its Liabilities from Discontinued Operations was $38.0 million in Q4 2017, compared to $38.0 million in Q3 2017 and $116.0 million in Q4 2016.